Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine + dexmedetomidine vs sufentanil for PONV after TMJ fixation
ChiCTR2600127092Phase 4Not yet recruiting
- Sponsor
- Shanghai Ninth People's Hospital
- Start
- Jun 2026
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in postoperative nausea and vomiting (PONV), postoperative pain and temporomandibular disorder (TMD) comparing Esketamine + dexmedetomidine with Sufentanil (2 arms). Primary endpoint: Incidence of postoperative nausea and vomiting within 48 hours. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
esketaminedexmedetomidinesufentanil
03
Conditions
postoperative nausea and vomiting (PONV)postoperative paintemporomandibular disorder (TMD)
Beyond the preview
Go deeper on ChiCTR2600127092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600127092.